A detailed history of High Tower Advisors, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 31,968 shares of INVA stock, worth $612,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,968
Previous 38,110 16.12%
Holding current value
$612,187
Previous $625,000 1.44%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$16.33 - $20.04 $100,298 - $123,085
-6,142 Reduced 16.12%
31,968 $616,000
Q2 2024

Aug 13, 2024

SELL
$14.4 - $16.4 $6,912 - $7,871
-480 Reduced 1.24%
38,110 $625,000
Q1 2024

May 06, 2024

SELL
$14.56 - $16.78 $42,078 - $48,494
-2,890 Reduced 6.97%
38,590 $588,000
Q4 2023

Feb 12, 2024

BUY
$12.32 - $16.27 $2,439 - $3,221
198 Added 0.48%
41,480 $665,000
Q3 2023

Nov 08, 2023

SELL
$12.37 - $13.89 $48,626 - $54,601
-3,931 Reduced 8.69%
41,282 $536,000
Q2 2023

Aug 14, 2023

BUY
$11.39 - $13.72 $4,100 - $4,939
360 Added 0.8%
45,213 $575,000
Q1 2023

May 11, 2023

BUY
$10.73 - $13.6 $87,567 - $110,989
8,161 Added 22.24%
44,853 $504,000
Q4 2022

Feb 08, 2023

BUY
$11.8 - $13.78 $432,965 - $505,615
36,692 New
36,692 $486,000
Q4 2021

Feb 10, 2022

SELL
$15.91 - $18.72 $1.83 Million - $2.15 Million
-114,764 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$13.06 - $17.24 $1.5 Million - $1.98 Million
114,764 New
114,764 $1.92 Million
Q1 2019

May 15, 2019

SELL
$13.69 - $20.06 $862,757 - $1.26 Million
-63,021 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.96 - $18.26 $879,773 - $1.15 Million
63,021 New
63,021 $1.1 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.33B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.